期刊
TRENDS IN IMMUNOLOGY
卷 34, 期 7, 页码 350-359出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.it.2013.02.003
关键词
miRNA; inflammation; monocyte; tumor-associated macrophage; cancer
类别
资金
- European Research Council (ERC)
- National Centres of Competence in Research (Oncology Program)
- Fonds National Suisse de la Recherche Scientifique (SNSF)
- Anna Fuller fund
- US National Institutes of Health (NIH) [R01-AI084880, P50-CA086355, U54-CA126515]
Deregulation of microRNAs (miRNAs) can drive oncogenesis, tumor progression, and metastasis by acting cell-autonomously in cancer cells. However, solid tumors are also infiltrated by large amounts of non-neoplastic stromal cells, including macrophages, which express several active miRNAs. Tumor-associated macrophages (TAMs) enhance angiogenic, immunosuppressive, invasive, and metastatic programming of neoplastic tissue and reduce host survival. Here, we review the role of miRNAs (including miR-155, miR-146, and miR-511) in the control of macrophage production and activation, and examine whether reprogramming miRNA activity in TAMs and/or their precursors might be effective for controlling tumor progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据